ALDOCK

About:

ALDOCK is a healthcare technology company that develops a risk test to help in early detection of cancer.

Website: http://www.aldock.co.jp

Top Investors: Incubate Fund, Lifetime Ventures

Description:

ALDOCK develops a groundbreaking risk test that will help in the early detection of cancer. The company is conducting research and development of risk tests that will help in the early detection of cancer. ALDOCK analyzes biomarker measurement results by machine learning to constantly improve inspection accuracy, and also construct an NGS analysis pipeline for that purpose. It provides a secure API / SDK that can be shared with other applications, as well as the inspection result can be confirmed by the user from the application.

Total Funding Amount:

80M JPY

Headquarters Location:

Shinjuku, Yamanashi, Japan

Founded Date:

2016-12-01

Founders:

Mabuchi Shingo

Number of Employees:

11-50

Last Funding Date:

2019-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai